Clinical Trial Update: Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494

View source ↗

Summary

This update reports on a biomarker study using tissue samples from older patients with diffuse large B-cell lymphoma treated with combination chemotherapy with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lymphoma | Status: COMPLETED